The Single-use Bioprocessing Probes and Sensors Market is expected to witness steady growth, driven by increased demand for disposable bioprocessing technologies and advancements in biotechnology across pharmaceutical and biopharmaceutical sectors.
NEWARK, DE / ACCESSWIRE / September 24, 2024 / The global Single-use Bioprocessing Probes and Sensors Market is poised for significant growth from 2024 to 2034. Estimated to reach a value of USD 3,051.6 million in 2024, the market is projected to expand at a CAGR of 5.8%, reaching USD 5,362.7 million by 2034. The increasing adoption of single-use technologies across the biopharmaceutical industry is one of the key factors driving this growth.
Understanding the Single-Use Bioprocessing Probes and Sensors Market:
Single-use bioprocessing probes and sensors play a critical role in ensuring efficient monitoring and control of bioprocesses. These devices are designed for single-use, reducing the risk of contamination and improving operational efficiency. The rising demand for biologics and biosimilar, along with advancements in disposable medical sensor technologies, is propelling the market forward.
In addition to this, the market is witnessing a shift towards cost-effective, scalable solutions in bioprocessing. Single-use probes and sensors are being increasingly favoured over traditional systems due to their flexibility, reduced cleaning requirements, and ability to optimize workflows in biopharmaceutical production.
As bio manufacturing processes evolve, the integration of advanced sensing technologies is expected to further fuel the market, allowing for real-time monitoring and control, which is essential in improving process efficiency and product quality.
The Single-Use Bioprocessing Probes and Sensors Market: Report Scope Country-wise Insights:
Countries | Value CAGR (2024 to 2034) |
Canada | 3.1% |
Spain | 3.4% |
France | 2.9% |
South Korea | 4.6% |
China | 5.8% |
Australia | 2.7% |
Drivers and Opportunities:
The market is primarily driven by the rising demand for biopharmaceuticals and the need for flexible, scalable production processes. Single-use probes and sensors offer numerous advantages, including reduced cleaning and sterilization costs, which makes them particularly attractive for small-scale and pilot production.
Increased focus on process automation and real-time monitoring in biopharmaceutical production is also creating lucrative opportunities for the adoption of advanced single-use bioprocessing sensors. The development of novel sensor technologies that offer enhanced accuracy and sensitivity is expected to further boost market growth.
Furthermore, the market is likely to benefit from the growing regulatory support for single-use systems in bioprocessing applications. Several government initiatives aimed at fostering innovation in biologics manufacturing are expected to open new avenues for market players.
Key Takeaways from Market Study:
The Single-use Bioprocessing Probes and Sensors Market is expected to grow at a CAGR of 5.8% between 2024 and 2034.
The market is projected to increase from USD 3,051.6 million in 2024 to USD 5,362.7 million by 2034.
Rising adoption of biologics and biosimilar in the pharmaceutical industry is driving demand for single-use technologies.
Advancements in sensor technologies that offer real-time monitoring capabilities are boosting market growth.
"The growth in the global single-use bioprocessing probes and sensors market is primarily driven by the increasing demand for sterility and contamination control in biopharmaceutical manufacturing. The use of single-use probes and sensors significantly reduces the risk of cross-contamination-a critical factor in ensuring consistent product quality and patient safety". Says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Component Insights:
The market is segmented based on component types such as pH sensors, oxygen sensors, pressure sensors, and temperature sensors. Among these, pH sensors and oxygen sensors are anticipated to hold a significant share, owing to their critical role in maintaining optimal conditions for cell growth and product yield in bioprocessing applications.
Temperature and pressure sensors are also expected to witness substantial growth as process monitoring and control become increasingly important in bio manufacturing operations. The continuous development of advanced disposable sensors offering greater accuracy and integration capabilities will further propel market growth.
Market's Prime Determinants of Growth, Trends and Opportunities:
The growing demand for single-use technologies in biopharmaceutical manufacturing, driven by increasing biologics production, is a key determinant of market growth. Technological advancements in sensor designs, such as miniaturization and enhanced real-time data capabilities, are creating new opportunities for market expansion.
Trends towards the integration of automation in bioprocessing and the adoption of Industry 4.0 solutions are further propelling market growth. Additionally, increasing investments in biopharmaceutical infrastructure, especially in emerging economies, are expected to provide a significant boost to the market.
Key Companies & Market Share Insights:
Thermos Fisher Scientific remains a leader in the market, with a wide range of products catering to biopharmaceutical production.
Sartorius AG and Danaher Corporation are also key players, offering advanced single-use sensors that cater to evolving bioprocessing needs.
GE Healthcare has made significant contributions through its innovative single-use technologies, ensuring a strong presence in the global market.
Growth Drivers:
Increasing biopharmaceutical production and the rise of biologics and biosimilar.
Cost-effective and scalable production processes provided by single-use systems.
Technological advancements in sensor technologies enabling real-time process monitoring.
Regulatory support for single-use systems in the biopharmaceutical industry.
Competitive Landscape:
Key players in the single-use bioprocessing probes and sensors market are heavily focusing on developing advanced, reliable, and efficient products to enhance their offerings. Additionally, many companies are actively pursuing strategic partnerships, mergers, and acquisitions to expand their geographical footprint and bolster their market share.
Recent Developments in the Single-Use Bioprocessing Probes and Sensors Market:
In November 2023, The Bio-Process Systems Alliance (BPSA), a global trade association, introduced its updated Single-Use Manufacturing Component Quality Test Matrices (QTM) for 2023, setting new standards in the industry.
In May 2023, Qosina, a leading supplier of single-use components for OEMs, launched its latest bioprocessing components catalog, which features over 1,500 new items designed to meet the growing demand in the market.
To Gain In-Depth Insights on Market, Browse Complete Report:https://www.futuremarketinsights.com/reports/single-use-bioprocessing-probes-and-sensors-market
Key Players of Single-use Bioprocessing Probes and Sensors Industry:
Sartorius AG
Thermo Fisher Scientific
Danaher Corporation
PreSens Precision Sensing GmbH
ABEC
Hamilton Company
PendoTECH LLC
Equflow
Parker Hannifin Corporation
Malema Engineering Corporation
Dover Corporation
Broadley-James Corporation
High Purity New England, Inc.
Cole-Parmer Instrument Company, LLC
ESI Ultrapure
Key Segments of Single-use Bioprocessing Probes and Sensors Industry:
By Sensor Type:
In terms of sensor type, the industry is divided into pH sensor, oxygen sensor, pressure sensors, temperature sensors, conductivity sensors, flow meters & sensors and other sensor types
By Workflow:
In terms of workflow, the industry is divided into Upstream and downstream
By End User:
In terms of end use, the industry is divided into biopharmaceutical manufacturer and labs & academic/ clinical research institutes
By Region:
Key countries of North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA), have been covered in the report.
Author By
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI's Extensive Coverage in the Healthcare Domain:
The global market for upstream bioprocessing equipment was worth USD 7.75 billion in 2022 and is predicted to increase at a CAGR of 12.90% between 2022 and 2032.
The portable bioprocessing bioreactors market is anticipated to flourish at a healthy CAGR of 14.6% between 2023 and 2033.
Bioprocessing Analytics Equipment Market revenue is set to total USD 485.1 Million in 2022. The global market is expected to reach USD 633.6 Million by 2028, rising at a CAGR of 4.5%.
The global single-use bioreactors market size is expected to reach a valuation of USD 18.9 billion by 2033. A valuation of USD 4.5 billion is anticipated for the market by the end of 2023.
According to Future Market Insights (FMI) analysis in a recent market survey, the global single-use gastroscopes market was valued at USD 167.2 Million in 2022 and is expected to reach USD 807.8 Million by 2033.
The worldwide next-generation titrator market size is expected to reach USD 7,171.9 million by 2034, owing to a moderate CAGR of 6.5% through the forecast period.
As per the analysis of Future Market Insights, the expected development of the global nonvascular interventional radiology device market is likely to adhere to a CAGR of 4.9%.
The pressure infusion cuffs market size is estimated to ascend at a valuation of approximately USD 350.8 million by 2024 as per Future Market Insights report.
According to Future Market Insights research, during the projected period, the global irradiation apparatus market is expected to garner a CAGR of 3.5%.
The global cancer-focused genetic testing service market size is likely to reach a valuation of USD 8,472.70 million by 2024.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the United Kingdom, the United States, and India. FMI's latest market research reports and industry analysis helps businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.
Contact Us
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Website:https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
SOURCE: Future Market Insights, Inc.